Raytel and St Jude develop ICD (implantable cardioverter defibrillators) monitoring system:
This article was originally published in Clinica
Raytel Medical and St Jude Medical are to complete the development of Housecall, a dedicated transtelephonic system for monitoring St Jude's Ventritex implantable cardioverter defibrillators (ICDs). Raytel, of San Mateo, California, already has a monitoring system for 81,000 pacemaker patients in the US. The new system will enable technicians to transmit stored and real-time information on cardiac activity and ICD performance. The results are interpreted and a report transferred to the physician for evaluation.
You may also be interested in...
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.